Zeng Qing-Yi, Fan Tian-Tian, Zhu Pan, He Ru-Qian, Bao Yi-Xin, Zheng Rong-Yuan, Xu Hui-Qin
Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, P.R. China.
Rehabilitation Center, The First Hospital of Zibo, Zibo, Shandong Province, P.R. China.
PLoS One. 2015 Jul 6;10(7):e0131566. doi: 10.1371/journal.pone.0131566. eCollection 2015.
To evaluate and compare long-term effectiveness of five antiepileptic drugs (AEDs) for monotherapy of adult patients with focal epilepsy in routine clinical practice.
Adult patients with focal epilepsy, who were prescribed with carbamazepine (CBZ), valproate (VPA), lamotrigine (LTG), topiramate (TPM), or oxcarbazepine (OXC) as monotherapy, during the period from January 2004 to June 2012 registered in Wenzhou Epilepsy Follow Up Registry Database (WEFURD), were included in the study. Prospective long-term follow-up was conducted until June 2013. The endpoints were time to treatment failure, time to seizure remission, and time to first seizure.
This study included 654 patients: CBZ (n=125), VPA (n=151), LTG (n=135), TPM (n=76), and OXC (n=167). The retention rates of CBZ, VPA, LTG, TPM, and OXC at the third year were 36.1%, 32.4%, 57.6%, 37.9%, and 41.8%, respectively. For time to treatment failure, LTG was significantly better than CBZ and VPA (LTG vs. CBZ, hazard ratio, [HR] 0.80 [95% confidence interval: 0.67-0.96], LTG vs. VPA, 0.53 [0.37-0.74]); TPM was worse than LTG (TPM vs. LTG, 1.77 [1.15-2.74]), and OXC was better than VPA (0.86 [0.78-0.96]). After initial target doses, the seizure remission rates of CBZ, VPA, LTG, TPM, and OXC were 63.0%, 77.0%, 83.6%, 67.9%, and 75.3%, respectively. LTG was significantly better than CBZ (1.44 [1.15-1.82]) and OXC (LTG vs. OXC, 0.76 [0.63-0.93]); OXC was less effective than LTG in preventing the first seizure (1.20 [1.02-1.40]).
LTG was the best, OXC was better than VPA only, while VPA was the worst. The others were equivalent for comparisons between five AEDs regarding the long-term treatment outcomes of monotherapy for adult patients with focal epilepsy in a clinical practice. For selecting AEDs for these patients among the first-line drugs, LTG is an appropriate first choice; others are reservation in the first-line but VPA is not.
评估并比较五种抗癫痫药物(AEDs)在常规临床实践中对成年局灶性癫痫患者单药治疗的长期疗效。
纳入2004年1月至2012年6月期间在温州癫痫随访登记数据库(WEFURD)中登记的、接受卡马西平(CBZ)、丙戊酸盐(VPA)、拉莫三嗪(LTG)、托吡酯(TPM)或奥卡西平(OXC)单药治疗的成年局灶性癫痫患者。进行前瞻性长期随访至2013年6月。终点指标为治疗失败时间、癫痫发作缓解时间和首次发作时间。
本研究共纳入654例患者:CBZ组(n = 125)、VPA组(n = 151)、LTG组(n = 135)、TPM组(n = 76)和OXC组(n = 167)。CBZ、VPA、LTG、TPM和OXC在第三年的保留率分别为36.1%、32.4%、57.6%、37.9%和41.8%。在治疗失败时间方面,LTG显著优于CBZ和VPA(LTG对比CBZ,风险比[HR] 0.80 [95%置信区间:0.67 - 0.96],LTG对比VPA,0.53 [0.37 - 0.74]);TPM比LTG差(TPM对比LTG,1.77 [1.15 - 2.74]),OXC优于VPA(0.86 [0.78 - 0.96])。在初始目标剂量后,CBZ、VPA、LTG、TPM和OXC的癫痫发作缓解率分别为63.0%、77.0%、83.6%、67.9%和75.3%。LTG显著优于CBZ(1.44 [1.15 - 1.82])和OXC(LTG对比OXC,0.76 [0.63 - 0.93]);在预防首次发作方面,OXC不如LTG有效(1.20 [1.02 - 1.40])。
LTG最佳,OXC仅优于VPA,而VPA最差。在临床实践中,对于成年局灶性癫痫患者单药治疗的长期疗效比较,五种AEDs中的其他药物相当。在一线药物中为这些患者选择AEDs时,LTG是合适的首选;其他药物可作为一线备选但VPA除外。